Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 4/20 | 0.55 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.55 |
| ▸ | NTSR1 | P30989 | 4/20 | 0.52 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.51 |
| ▸ | NMUR2 | Q9GZQ4 | 4/20 | 0.51 |
| ▸ | CXCL8 | P10145 | 3/20 | 0.51 |
| ▸ | NMUR1 | Q9HB89 | 3/20 | 0.50 |
| ▸ | NPY1R | P25929 | 2/20 | 0.50 |
| ▸ | RAMP3 | O60896 | 1/20 | 0.50 |
| ▸ | CALCR | P30988 | 1/20 | 0.50 |
| ▸ | F2 | P00734 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30745223 | 0.90 | SLC6A2 (0.56) | NTSR1NTSR2NMUR2NPY1R | |
| SCHEMBL30420836 | 0.89 | NAA50 (0.50) | OPRM1OPRD1NTSR1RAMP3CALCR | |
| SCHEMBL30419465 | 0.88 | NAA50 (0.53) | NMUR2CXCL8NMUR1NPY1RRAMP3 | |
| SCHEMBL30420364 | 0.88 | NAA50 (0.49) | OPRM1OPRD1NMUR2NMUR1RAMP3 | |
| SCHEMBL30767697 | 0.86 | CALCR (0.59) | OPRM1OPRD1NTSR1RAMP3CALCR | |
| SCHEMBL30767678 | 0.85 | CALCR (0.57) | OPRM1OPRD1NTSR1NTSR2RAMP3 | |
| SCHEMBL29419165 | 0.84 | OPRD1 (0.61) | OPRM1OPRD1NMUR2NMUR1 | |
| SCHEMBL29896174 | 0.83 | SLC6A2 (0.56) | OPRM1OPRD1NTSR1NTSR2CXCL8 | |
| SCHEMBL30567427 | 0.83 | OPRM1 (0.56) | OPRM1OPRD1 | |
| SCHEMBL29569464 | 0.83 | OPRM1 (0.55) | OPRM1OPRD1NTSR1NTSR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116350760-A | Application of CTL epitope peptide derived from new antigen ESR1 or encoding nucleic acid thereof in preparation of medicines | 郑州大学 | 2023-06-30 | — | — | CN | disclosed |